AUREALIS PHARMA
DEAD

Serial Number

87114798

Owner

Aurealis Pharma AG

Attorney

R. Glenn Schroeder

Filing Date

Jul 25, 2016

Add to watchlist:

No watchlists yet
View on USPTO

AUREALIS PHARMA Trademark

Serial Number: 87114798 • Registration: 5383359

AUREALIS PHARMA is a trademark filed by Aurealis Pharma AG on July 25, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Aurealis Pharma AG (2 trademarks)

Greifengasse 11
Basel 4058 , CH

Entity Type: 99

Trademark Details

Filing Date

July 25, 2016

Registration Date

January 23, 2018

Published for Opposition

October 17, 2017

Cancellation Date

August 2, 2024

Goods & Services

Pharmaceutical and veterinary preparations, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; sanitary preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; dietetic food and substances, namely, fermented milk products, drinks and gum, adapted for medical or veterinary use; dietary supplements for humans and animals; health care products, namely, plasters, materials for dressings, ointments, sprays, injections, human therapeutics, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; disinfectants; preparations for destroying vermin; fungicides and herbicides; pharmaceuticals, biosimilars, medicine, drugs, namely, immunomodulators and anticancer agents, antibodies, antibody fragments, checkpoint inhibitors and checkpoint modifiers, vaccines, for human beings and animals; prokaryotic organisms, namely, genetically modified bacteria, bacteria producing growth factors, antibodies, immunomodulators, anticancer agents, checkpoint inhibitors and checkpoint modifiers and vaccines; medicines for human purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; medicines for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; bacteriological preparations for medical and veterinary use, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for pharmaceutical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; pharmaceutical and veterinary preparations and substances in particular for the treatment of cancer, inflammatory diseases, immune system related diseases, specifically autoimmune disorders, and other conditions which can be treated or ameliorated by antibodies or antibody fragments binding to, activating or blocking of a target antigen or ameliorated by immunomodulating factors, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 2, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 23, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2018 R.PR
NOTICE OF ALLOWANCE CANCELLED
Dec 15, 2017 IUCN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2017 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2017 CRFA
ASSIGNED TO LIE
Aug 10, 2017 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 14, 2017 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 12, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
May 12, 2017 GNSL
SUSPENSION LETTER WRITTEN
May 12, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 9, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 10, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 10, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 10, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2016 NWOS
NEW APPLICATION ENTERED
Jul 28, 2016 NWAP